HTTP/1.1 302 Found
Date: Wed, 17 Apr 2024 20:06:38 GMT
Content-Type: text/html; charset=utf-8
Content-Length: 147
Connection: keep-alive
Access-Control-Expose-Headers: Request-Context
Cache-Control: public, max-age=31536000
Location: https://www.novartis.com/about
Set-Cookie: ARRAffinity=3f9d827905dba19edf4c3eb033da1b2cce776a4f8bbe0e42467b9f96a1cde502;Path=/;HttpOnly;Secure;Domain=www.nsclcbiomarkers.com
Set-Cookie: ARRAffinitySameSite=3f9d827905dba19edf4c3eb033da1b2cce776a4f8bbe0e42467b9f96a1cde502;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.nsclcbiomarkers.com
Strict-Transport-Security: max-age=31536000; includeSubDomains
Request-Context: appId=cid-v1:fbded6d8-2f5c-4cb0-adf7-2ae9d814644f
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
CF-Cache-Status: DYNAMIC
Server: cloudflare
CF-RAY: 875f0968b8f667f0-SJC
SSL Certificate
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
2d:24:90:56:d0:01:be:3c:c1:5f:88:a4:d6:e4:ba:9e
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=GB, ST=Greater Manchester, L=Salford, O=Sectigo Limited, CN=Sectigo RSA Organization Validation Secure Server CA
Validity
Not Before: Oct 12 00:00:00 2023 GMT
Not After : Jul 13 23:59:59 2024 GMT
Subject: C=US, ST=New Jersey, O=Novartis Pharmaceuticals Corporation, CN=access.novartis.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:eb:62:1c:c3:fa:8a:86:17:e4:a7:17:fa:dc:5d:
20:e1:1f:ca:3a:1e:9a:9f:98:f0:b2:a6:33:a0:a5:
af:1b:9d:7e:23:bf:47:71:3b:a5:31:39:38:13:82:
b1:ca:67:77:f0:54:15:32:f5:da:49:18:c3:5f:e1:
dd:98:97:5c:6d:9a:19:3a:d4:47:d1:d7:2c:a4:d6:
be:1c:70:6d:4d:fb:f6:ea:69:f1:0b:8a:0b:a3:3c:
1d:02:ec:df:4d:ff:ad:12:84:0f:1d:de:d2:56:1f:
86:f7:fc:cb:d9:79:a1:63:fb:ac:10:f0:ae:d3:0a:
47:fe:39:75:1e:96:9b:0a:1d:9c:c6:c0:1c:fc:85:
2a:df:a6:f8:5d:34:4e:c3:d6:e6:29:37:32:c4:9e:
c5:06:a4:16:6c:3e:5a:4b:96:05:31:de:7d:b5:bc:
f1:fa:38:a0:b1:97:53:ac:d6:c2:8a:11:48:71:c2:
c2:ed:45:2c:ee:45:32:71:6a:a2:f8:ec:76:81:df:
53:b5:cd:9b:44:c7:d8:03:60:56:1b:b7:15:ec:2d:
11:ed:11:8d:e9:ae:9b:5b:d0:72:ef:00:3b:81:e7:
7d:26:da:67:ba:97:2a:fc:48:d5:88:03:46:a8:11:
7f:1a:1c:b0:1e:41:5f:2d:a9:1e:0e:4e:7b:22:fb:
4c:a7
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Authority Key Identifier:
17:D9:D6:25:27:67:F9:31:C2:49:43:D9:30:36:44:8C:6C:A9:4F:EB
X509v3 Subject Key Identifier:
C3:06:FF:B3:8A:CF:10:81:C9:D0:86:8B:BE:5E:14:23:B9:B4:33:30
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Basic Constraints: critical
CA:FALSE
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Certificate Policies:
Policy: 1.3.6.1.4.1.6449.1.2.1.3.4
CPS: https://sectigo.com/CPS
Policy: 2.23.140.1.2.2
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crl
Authority Information Access:
CA Issuers - URI:http://crt.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crt
OCSP - URI:http://ocsp.sectigo.com
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 76:FF:88:3F:0A:B6:FB:95:51:C2:61:CC:F5:87:BA:34:
B4:A4:CD:BB:29:DC:68:42:0A:9F:E6:67:4C:5A:3A:74
Timestamp : Oct 12 16:00:07.518 2023 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:77:B6:0F:72:8F:5B:F8:F6:65:01:DB:EB:
0B:3D:FA:91:63:D9:C4:6F:DC:16:6D:2A:D5:47:3D:20:
12:72:83:B0:02:20:08:98:CF:AE:6F:96:EB:27:C0:23:
23:A1:9E:65:D1:E5:47:F7:77:31:B9:96:15:2E:7B:DE:
86:D6:88:CD:6B:C4
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : DA:B6:BF:6B:3F:B5:B6:22:9F:9B:C2:BB:5C:6B:E8:70:
91:71:6C:BB:51:84:85:34:BD:A4:3D:30:48:D7:FB:AB
Timestamp : Oct 12 16:00:07.598 2023 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:46:02:21:00:D6:F3:AC:0A:8D:83:9F:06:EE:D3:EA:
BD:F6:30:0F:11:67:35:C3:8B:07:35:B9:45:BE:ED:C7:
51:F3:09:51:57:02:21:00:92:B4:47:58:71:B1:1B:A5:
E9:3C:84:02:1B:27:CD:48:BE:E5:6D:49:7F:38:9C:25:
1D:00:1E:95:56:1A:F8:1C
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : EE:CD:D0:64:D5:DB:1A:CE:C5:5C:B7:9D:B4:CD:13:A2:
32:87:46:7C:BC:EC:DE:C3:51:48:59:46:71:1F:B5:9B
Timestamp : Oct 12 16:00:07.632 2023 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:21:00:E1:31:54:64:30:86:59:0C:B3:CE:8B:
C9:AF:68:62:CB:A7:02:09:BA:89:38:A5:D6:69:9F:7B:
F1:72:DC:1F:8F:02:20:5A:82:B0:64:FB:0B:F0:D1:DC:
35:0A:35:BB:F0:EC:41:4C:C8:CB:FE:1D:BC:C7:DE:70:
EA:BF:F2:27:65:A9:C4
X509v3 Subject Alternative Name:
DNS:access.novartis.com, DNS:ADAKVEO-HCP.com, DNS:ADAKVEO-NurseResources.com, DNS:Discover-Tabrecta.com, DNS:Explore-Tabrecta.com, DNS:GetSickleCellHelp.com, DNS:METinNSCLC.com, DNS:NSCLCmutation.com, DNS:Rx-Tabrecta.com, DNS:Sandostatin-access.com, DNS:Sandostatin-administration.com, DNS:Sandostatin-hcp.com, DNS:Sandostatin-training.com, DNS:Target-mNSCLC.com, DNS:TargetedTrial.com, DNS:Targetlungcancer.com, DNS:advanced-breastcancer.com, DNS:brafv600e.com, DNS:cml-treatment.com, DNS:cmlbasics.com, DNS:copayrequestform.com, DNS:gleevec.com, DNS:hcp-tabrecta.com, DNS:ironoverload.com, DNS:kisqali-parami.com, DNS:makingsandostatin.com, DNS:medexpertlibrary.com, DNS:mobilecarcinoidhcp.com, DNS:mobilecarcinoidpatient.com, DNS:nsclcbiomarkers.com, DNS:phenotypicprecisionmedicine.com, DNS:pik3ca-cdx-order.com, DNS:pik3ca-cdx.com, DNS:promacta.com, DNS:sandostatin-dosing.com, DNS:sandostatin-hcp-us.com, DNS:sandostatin-us.com, DNS:sandostatinsupport.com, DNS:start-tabrecta.com, DNS:tabrecta-hcp.com, DNS:tafinlarandmekinistcombo.com, DNS:tafinlarmekinistcombo.com, DNS:tasigna-hcp.com, DNS:treatingcarcinoidsyndrome.com, DNS:us.jadenu.com, DNS:us.vijoice.com, DNS:ustasigna.com, DNS:vijoice.com, DNS:whataboutmycml.com, DNS:www.ADAKVEO-HCP.com, DNS:www.ADAKVEO-NurseResources.com, DNS:www.Discover-Tabrecta.com, DNS:www.Explore-Tabrecta.com, DNS:www.GetSickleCellHelp.com, DNS:www.METinNSCLC.com, DNS:www.NSCLCmutation.com, DNS:www.Rx-Tabrecta.com, DNS:www.Sandostatin-access.com, DNS:www.Sandostatin-administration.com, DNS:www.Sandostatin-hcp.com, DNS:www.Sandostatin-training.com, DNS:www.Target-mNSCLC.com, DNS:www.TargetedTrial.com, DNS:www.Targetlungcancer.com, DNS:www.advanced-breastcancer.com, DNS:www.brafv600e.com, DNS:www.cml-treatment.com, DNS:www.cmlbasics.com, DNS:www.copayrequestform.com, DNS:www.gleevec.com, DNS:www.hcp-tabrecta.com, DNS:www.ironoverload.com, DNS:www.kisqali-parami.com, DNS:www.makingsandostatin.com, DNS:www.medexpertlibrary.com, DNS:www.mobilecarcinoidhcp.com, DNS:www.mobilecarcinoidpatient.com, DNS:www.nsclcbiomarkers.com, DNS:www.phenotypicprecisionmedicine.com, DNS:www.pik3ca-cdx-order.com, DNS:www.pik3ca-cdx.com, DNS:www.promacta.com, DNS:www.sandostatin-dosing.com, DNS:www.sandostatin-hcp-us.com, DNS:www.sandostatin-us.com, DNS:www.sandostatinsupport.com, DNS:www.start-tabrecta.com, DNS:www.tabrecta-hcp.com, DNS:www.tafinlarandmekinistcombo.com, DNS:www.tafinlarmekinistcombo.com, DNS:www.tasigna-hcp.com, DNS:www.treatingcarcinoidsyndrome.com, DNS:www.us.jadenu.com, DNS:www.us.vijoice.com, DNS:www.ustasigna.com, DNS:www.vijoice.com, DNS:www.whataboutmycml.com
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
03:7c:7d:ee:af:35:23:68:32:65:f3:81:14:b5:c8:83:67:a8:
b3:fb:0e:53:89:0e:db:af:a2:e0:4c:55:77:03:66:89:e7:b4:
82:dc:98:8d:46:80:80:cf:3d:1a:0e:f7:bf:5f:c0:31:08:f1:
10:0e:e8:c3:8f:b2:97:30:42:ae:43:3b:e3:a3:a4:7a:f1:31:
07:b3:6b:36:10:ed:4b:f7:56:cf:20:06:60:2e:a9:72:4b:b4:
91:e7:06:77:c4:b2:77:bc:15:7f:be:8a:63:32:a2:01:e9:6e:
e7:7c:78:00:33:8a:08:f0:c4:57:62:5d:d4:d0:0c:37:a0:c3:
0c:14:5e:9c:25:0a:b7:e3:95:10:3f:a7:04:52:ad:53:65:65:
a7:4f:a8:ce:94:89:6b:cd:58:48:6f:d6:2e:aa:30:0a:a0:b1:
a2:b4:59:d7:d0:87:52:24:ea:97:d8:6f:91:90:f9:d7:41:05:
ce:78:10:b2:7a:f5:f4:71:35:fb:2a:c3:15:51:7b:4d:c8:b0:
e7:03:9d:a8:59:9d:d0:4a:a6:d7:9a:64:ad:bd:2b:1b:d6:3f:
00:c2:93:c0:53:6a:e8:d7:dd:79:e4:0b:88:bb:4f:67:8b:f8:
e5:ad:2a:c6:ae:9a:28:8c:3f:17:d0:fc:26:75:7b:c0:f5:a2:
0c:0f:cb:01
